![Sarepta Therapeutics, Inc. logo](/logos/SRPT.webp)
Sarepta Therapeutics, Inc.
NASDAQ:SRPT
Overview | Financials
Company Name | Sarepta Therapeutics, Inc. |
Symbol | SRPT |
Currency | USD |
Price | 128.92 |
Market Cap | 12,294,623,396 |
Dividend Yield | 0% |
52-week-range | 55.25 - 173.25 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Douglas S. Ingram Esq. |
Website | https://www.sarepta.com |
An error occurred while fetching data.
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD